The FDA has approved generic versions of GlaxoSmithKline’s ondansetron Zofran Injection and Zofran Injection Premixed. Ondansetron canadian is indicated for preventing chemosurgery-associated and postoperative nausea and vomiting.

The injection (Teva Pharmaceuticals) is available in single (4-mg/2 ml) and multidose (40-mg/20 ml) packages. The premixed product (32 mg/50 ml in 5% dextrose) is manufactured by Sicor Pharmaceuticals.

Random Posts:

• Metformin Kills Breast Cancer Stem Cells in Mice
• Heart Attack Warning For Rosiglitazone (Avandia)
• FDA Update on Drug-Coated Stents
• Cognitive Therapy/Drug Combo Improves Irritable Bowel Syndrome
• IV Ibuprofen (Caldolor) For Pain and Fever